🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Recruitingn/aAges 7 Years - anyAllHacettepe University
NCT07182981 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance. Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
For a child diagnosed with scleroderma: Inclusion Criteria: * Cases diagnosed with scleroderma, * Cases aged 7-18 years will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Cases that are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study For adults diagnosed with scleroderma: Inclusion Criteria: * Individuals diagnosed with scleroderma, * Individuals over the age of 18 will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Individuals who are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study
💊

What it tests

  • Questionnaire application for child and adult scleroderma patients
📍

Where

1 site
Hacettepe University
Çankaya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy